935 Mearns Road
+1 845 255 5000
The SP modular Versa-Line Fill-finish system and Line of SightTM freeze dryer tools, technologies and equipment provide product development and configurable full line solutions. Specializing in small batch applications, the Versa-Line incorporates quick delivery standard modules for vial washing, depyrogenation tunnels, filling and stoppering, freeze dryer and freeze dryer loading systems, capping, external vial washers and trayloaders.
The SP i-Dositecno L3 50VPM filling line – an isolated 50 vials per minute linear line for pre-sterilized vials in trays, with glass to glass contact, and 100% IPC (net check weighing).
SP takes you on a visual case for increased profitability, batch homogeneity, and shorter run times during commercial lyophilization using controlled nucleation. Here, you will see how controlled nucleation can make your scale up seamless. ControLyo® Technology delivers a controlled process, improves product quality, shortens drying times and requires no formulation change of introduction of foreign material into the vials.
SP covers the complete range of aseptic processing tools and techniques, from cycle development, stability testing, pilot and clinical batch production through to full aseptic manufacturing and commercial production batches. Our expertise in processing and packaging is matched with in-depth software engineering capabilities and customer-orientated servicing and support.
SP is committed to customer-driven innovation and streamlining product development, including standard models, to enhance product quality and consistency, improve yield, and importantly accelerate time to market. SP’s unique Line of Sight™ approach provides a breakthrough suite of freeze-drying equipment, with scalable lyophilisation technologies and process analytical technologies (PAT) designed to enhance quality, improve productivity and increase return on investment.
Fill-finish is the final stage before the product is packaged and administered to the patient. As patient treatments move away from broad population therapies in favour of the targeted treatment of smaller (personalised) patient populations, the biopharmaceutical industry is transitioning to smaller aseptic batch manufacturing processes. Consequently, SP recognise their customers have a growing need for a complete package of rapid product development and scalable, good manufacturing (GMP) compliant, complete aseptic fill-finish production lines, optimised for small batch applications. Fill-finish is a crucial step in the biopharmaceutical manufacturing process, with small to medium batch aseptic filling and shorter “time to market” becoming increasingly important.
SP is a synergistic collection of well-known, well-established and highly regarded scientific equipment brands — SP VirTis, SP FTS, SP Hotpack, SP Hull, SP Genevac, SP PennTech and most recently SP i-Dositecno — joined to create one of the largest and most experienced companies in freeze drying/lyophilisation, complete aseptic fill-finish production lines, centrifugal evaporation and concentration, temperature control/thermal management, glassware washers and controlled environments.
SP is part of SP Industries, Inc. , a leading designer and manufacturer of state-of-the-art laboratory equipment, pharmaceutical manufacturing solutions, laboratory supplies and instruments, and specialty glassware. SP's products support research and production across divers end user markets including pharmaceutical, scientific research, industrial, aeronautic, semiconductor and healthcare. In December 2015, SP Industries was acquired by Harbour Group, a private investment firm founded in 1976. Harbour Group is a privately owned, operations focused company based in St. Louis, Missouri. Headquartered in Warminster, Pennsylvania, SP has production facilities in the USA and in Spain and the UK in Europe and offers a world-wide sales and service network with full product support including training and technical assistance. For more than 100 years, SP has transformed into a leading supplier to the worldwide scientific community …
Webinar Tech Notes: